CompuGroup stock reports quarterly revenue growth
Published on 10/05/2026 at 20:11 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
CompuGroup (ISIN DE000A288904) reported EUR 653.12 million in revenue for the quarter ended December 2025, up 10.0 percent from EUR 593.70 million in the prior quarter. The result gives investors a measurable update on the healthcare software provider before its next scheduled report.
Revenue rises to EUR 653.12 million
Investing.com lists revenue of EUR 653.12 million and earnings per share of EUR 0.23 for the period ending December 2025. The preceding quarter generated EUR 593.70 million in revenue, making the sequential increase a concrete comparison rather than a purely qualitative growth signal.
The revenue increase was accompanied by positive earnings, with EPS at EUR 0.23 for the quarter. The same release history lists the figures in EUR and identifies the period as December 2025, keeping the revenue and EPS figures tied to the same reporting period.
Healthcare software remains the core
CompuGroup Medical develops software and information technology for healthcare providers. Its activities cover ambulatory information systems, hospital information systems, pharmacy information systems and consumer and health management solutions, including practice management, electronic medical records, clinical administration and billing tools.
The company profile describes a customer base spanning physicians, medical centers, hospitals, pharmacies, laboratories, insurers and consumers. That breadth gives the revenue figure several operating channels, while the EUR 0.23 EPS figure shows that the quarter produced positive earnings alongside the higher sales base.
Next report is set for November
Investing.com lists November 5, 2026, as CompuGroup Medical's next earnings date. The scheduled release gives the market a defined checkpoint for the next quarterly revenue and earnings update.
Market value reaches EUR 1.5 billion
Market data for October 2, 2026, put CompuGroup Medical's market capitalization at EUR 1.5 billion. The same date carried a 52-week range of EUR 23.30 to EUR 30.40, placing the company's valuation against a clearly defined annual trading band.
Global Banking and Finance identifies CompuGroup Medical as COP.DE on Xetra and assigns the security to the Health Care sector. The listing data also confirm ISIN DE000A288904, matching the security covered here.
CompuGroup stock has a defined checkpoint
CompuGroup stock combines a 10.0 percent sequential revenue increase with EUR 0.23 quarterly EPS and a November 5 reporting date. For investors, the next release will show whether the December 2025 revenue level develops into a sustained growth pattern.
CompuGroup stock key facts
- Company: CompuGroup Medical SE & Co. KGaA
- ISIN: DE000A288904
- Ticker: COP.DE
- Trading venue: Xetra
- Market capitalization: EUR 1.5 billion (as of October 2, 2026)
- 52-week range: EUR 23.30-EUR 30.40 (as of October 2, 2026)
- Sector / Industry: Healthcare / Medical Healthcare Information Services
Upcoming dates for CompuGroup stock
- November 5, 2026: Quarterly earnings report
